The effect of STAT1 expression and the Y701 phosphorylation on primary Undifferentiated Pleomorphic Sarcoma cells
7 affiliations
- 1Lunenfeld-Tanenbaum Research Institute, Sinai Health System, Toronto, Canada.
- 2Department of Molecular Genetics, University of Toronto, Toronto, Canada.
- 3Department of Surgical Oncology, Princess Margaret Cancer Centre/Mount Sinai Hospital, Toronto, Canada.
- 4Department of Surgery, Mount Sinai Hospital, Sinai Health, Toronto, Canada.
- 5University of Toronto Musculoskeletal Oncology Unit, Division of Orthopaedic Surgery, Toronto, Canada.
- 6Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Canada.
- 7Institute of Medical Science, University of Toronto, Toronto, Canada.
Abstract
Undifferentiated Pleomorphic Sarcoma (UPS) is a genetically complex type of soft tissue sarcoma (STS) and there are few therapeutic options for advanced disease. Immune checkpoint blockade therapy may be of benefit to a subset of UPS patients, particularly those with elevated tumoral Programmed Cell Death Ligand 1 (PD-L1) expression and an inflamed tumour microenvironment. From transcriptomic analyses we previously identified Signal Transducer and Activator of Transcription 1 (STAT1) expression, a key mediator of interferon-γ (IFN-γ) signaling, as enriched in a cohort of UPS cases with elevated PD-L1 levels that were observed to have an improved clinical outcome. This led us to investigate the role of STAT1 in UPS biology. We examined the effects of STAT1 loss, and overexpression of either wild type or tyrosine phosphorylation-deficient STAT1 in primary human UPS cell lines. We observed that IFN-γ treatment decreased cell counts, increased cell death, and induced the secretion of CXCR3 ligands in a STAT1-dependent manner. Overexpression of wild type STAT1, but not a tyrosine to phenylalanine phospho-mutant (Y701F), restored IFN-γ-mediated cell death and cytokine secretion, highlighting the importance of Y701 phosphorylation in STAT1-associated antitumour functions. STAT1 Y701 phosphorylation status was associated with gene expression changes that were cell line specific. Together, these findings shed light on the central role of STAT1, and specifically the Y701 phosphorylation, in mediating IFN-γ signaling and related phenotypes. This study underscores the need for further exploration of the role of STAT1 phosphorylation in tumor-immune interactions within UPS.
Related
- SMARCB1/INI1-deficient Undifferentiated Carcinoma Presenting as Cancer of Unknown Primary with Massive Hepatic Involvement: Transient Response to FOLFOX plus Nivolumab
- Histone Lactylation Drives WNK1 Expression to Promote Esophageal Squamous Cell Carcinoma Progression Through Histone H3 Ser10 Phosphorylation
- In Situ Cytokine Expression, Nitric Oxide and Reactive Oxygen Species Production During Primary Amoebic Meningoencephalitis Development
- De novo transcriptomic analysis reveals salicylic acid-induced biosynthesis of vinblastine and vincristine in undifferentiated Catharanthus roseus callus
- Knockout and re-expression system for mutant analysis in primary mouse T cells
BibTeX
@article{coward2026effect,
title = {{The effect of STAT1 expression and the Y701 phosphorylation on primary Undifferentiated Pleomorphic Sarcoma cells}},
author = {Victoria S Coward and Nalan Gokgoz and Kim M Tsoi and Jay S Wunder and Irene L Andrulis},
journal = {PLOS One},
year = {2026},
month = oct,
doi = {10.1371/journal.pone.0361295},
url = {https://doi.org/10.1371/journal.pone.0361295},
note = {CC BY},
}
RIS
TY - JOUR
TI - The effect of STAT1 expression and the Y701 phosphorylation on primary Undifferentiated Pleomorphic Sarcoma cells
AU - Victoria S Coward
AU - Nalan Gokgoz
AU - Kim M Tsoi
AU - Jay S Wunder
AU - Irene L Andrulis
PY - 2026
DA - 2026/10/26
JO - PLOS One
DO - 10.1371/journal.pone.0361295
UR - https://doi.org/10.1371/journal.pone.0361295
AB - Undifferentiated Pleomorphic Sarcoma (UPS) is a genetically complex type of soft tissue sarcoma (STS) and there are few therapeutic options for advanced disease. Immune checkpoint blockade therapy may be of benefit to a subset of UPS patients, particularly those with elevated tumoral Programmed Cell Death Ligand 1 (PD-L1) expression and an inflamed tumour microenvironment. From transcriptomic analyses we previously identified Signal Transducer and Activator of Transcription 1 (STAT1) expression, a key mediator of interferon-γ (IFN-γ) signaling, as enriched in a cohort of UPS cases with elevated PD-L1 levels that were observed to have an improved clinical outcome. This led us to investigate the role of STAT1 in UPS biology. We examined the effects of STAT1 loss, and overexpression of either wild type or tyrosine phosphorylation-deficient STAT1 in primary human UPS cell lines. We observed that IFN-γ treatment decreased cell counts, increased cell death, and induced the secretion of CXCR3 ligands in a STAT1-dependent manner. Overexpression of wild type STAT1, but not a tyrosine to phenylalanine phospho-mutant (Y701F), restored IFN-γ-mediated cell death and cytokine secretion, highlighting the importance of Y701 phosphorylation in STAT1-associated antitumour functions. STAT1 Y701 phosphorylation status was associated with gene expression changes that were cell line specific. Together, these findings shed light on the central role of STAT1, and specifically the Y701 phosphorylation, in mediating IFN-γ signaling and related phenotypes. This study underscores the need for further exploration of the role of STAT1 phosphorylation in tumor-immune interactions within UPS.
SN - 1932-6203
ER -